Cargando…

Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin

Dietary supplements sold for anabolic benefits or performance enhancement often contain substances, which are non-approved and might lack quality controls. With regard to athletes, the inclusion of substances or methods in the prohibited list of the World Anti-Doping Agency is based on medical or sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Carolin, Keiler, Annekathrin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151512/
https://www.ncbi.nlm.nih.gov/pubmed/35344071
http://dx.doi.org/10.1007/s00204-022-03283-5
_version_ 1784717498564739072
author Beer, Carolin
Keiler, Annekathrin M.
author_facet Beer, Carolin
Keiler, Annekathrin M.
author_sort Beer, Carolin
collection PubMed
description Dietary supplements sold for anabolic benefits or performance enhancement often contain substances, which are non-approved and might lack quality controls. With regard to athletes, the inclusion of substances or methods in the prohibited list of the World Anti-Doping Agency is based on medical or scientific evidence. 5α-hydroxy-laxogenin is a synthetic spirostane-type steroid, which is contained in dietary supplements and advertised as anabolic agent. To date, evidence is missing on anabolic or androgenic activity of 5α-hydroxy-laxogenin. We investigated its androgenic potential in two in vitro bioassays. While no activity was observed in the yeast androgen screen, 5α-hydroxy-laxogenin was able to trans-activate the androgen receptor in human prostate cells in a dose-dependent manner. Interestingly, a biphasic response was observed with antagonistic properties at lower concentrations and agonistic effects at higher concentrations tested. The demonstrated androgenic properties of the higher concentrations demonstrate that further investigations should focus on the safety as well as on potential anabolic effects of 5α-hydroxy-laxogenin. This is of interest with regard to abuse for doping purposes.
format Online
Article
Text
id pubmed-9151512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91515122022-06-01 Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin Beer, Carolin Keiler, Annekathrin M. Arch Toxicol Short Communication Dietary supplements sold for anabolic benefits or performance enhancement often contain substances, which are non-approved and might lack quality controls. With regard to athletes, the inclusion of substances or methods in the prohibited list of the World Anti-Doping Agency is based on medical or scientific evidence. 5α-hydroxy-laxogenin is a synthetic spirostane-type steroid, which is contained in dietary supplements and advertised as anabolic agent. To date, evidence is missing on anabolic or androgenic activity of 5α-hydroxy-laxogenin. We investigated its androgenic potential in two in vitro bioassays. While no activity was observed in the yeast androgen screen, 5α-hydroxy-laxogenin was able to trans-activate the androgen receptor in human prostate cells in a dose-dependent manner. Interestingly, a biphasic response was observed with antagonistic properties at lower concentrations and agonistic effects at higher concentrations tested. The demonstrated androgenic properties of the higher concentrations demonstrate that further investigations should focus on the safety as well as on potential anabolic effects of 5α-hydroxy-laxogenin. This is of interest with regard to abuse for doping purposes. Springer Berlin Heidelberg 2022-03-28 2022 /pmc/articles/PMC9151512/ /pubmed/35344071 http://dx.doi.org/10.1007/s00204-022-03283-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Communication
Beer, Carolin
Keiler, Annekathrin M.
Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title_full Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title_fullStr Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title_full_unstemmed Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title_short Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
title_sort androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151512/
https://www.ncbi.nlm.nih.gov/pubmed/35344071
http://dx.doi.org/10.1007/s00204-022-03283-5
work_keys_str_mv AT beercarolin androgenicpropertiesofthedietarysupplement5ahydroxylaxogenin
AT keilerannekathrinm androgenicpropertiesofthedietarysupplement5ahydroxylaxogenin